Arena Pharmaceuticals to Present at the Evercore ISI HealthCONx Conference on December 1

Rhea-AI Summary

Arena Pharmaceuticals (Nasdaq: ARNA) announced that CEO Amit D. Munshi will participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on December 1, 2020, at 4:20 PM ET. A live webcast will be accessible on Arena's investor relations page at www.arenapharm.com, with a replay available for 30 days after the event. Arena focuses on delivering essential medicines to patients, emphasizing urgency and innovative approaches in a dynamic market.

SAN DIEGO, Nov. 24, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Tuesday, December 1, at 4:20 PM ET.

A live webcast of the presentation will be posted under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event.

About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose – deliver our important medicines to patients.

In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get our medicines to patients, and relentlessly execute until it's done.

ARENA - Care More. Act Differently.

Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's participation in and webcast of the virtual fireside chat presentation and Arena's purpose, work, understanding, ideas, and execution. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Corporate Contacts:
Patrick Malloy
Arena Pharmaceuticals, Inc.
Vice President, Investor Relations & Corporate Communications
pmalloy@arenapharm.com
847.987.4878

Megan E. Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations 
mknight@arenapharm.com
858.210.3635

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-at-the-evercore-isi-healthconx-conference-on-december-1-301179350.html

SOURCE Arena Pharmaceuticals, Inc.

FAQ

When will Arena Pharmaceuticals present at the Evercore ISI HealthCONx Conference?

Arena Pharmaceuticals will present at the Evercore ISI HealthCONx Conference on December 1, 2020, at 4:20 PM ET.

Who will represent Arena Pharmaceuticals at the conference?

Amit D. Munshi, the President and CEO, will represent Arena Pharmaceuticals at the conference.

How can I watch the Arena Pharmaceuticals presentation live?

You can watch the live webcast of Arena Pharmaceuticals' presentation on their investor relations page at www.arenapharm.com.

Is there a replay available for the Arena Pharmaceuticals conference presentation?

Yes, a replay of the presentation will be available for 30 days following the event.

What is the focus of Arena Pharmaceuticals as stated in the press release?

Arena Pharmaceuticals is focused on delivering essential medicines to patients, operating with urgency and innovative ideas.